Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

SHA:605077 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	5,141	4,384	4,385	5,077	6,931	6,829
Market Cap Growth	17.52%	-0.03%	-13.63%	-26.76%	1.50%	-
Enterprise Value	7,303	6,293	6,033	5,412	6,272	5,581
Last Close Price	17.17	14.78	14.07	15.42	21.17	20.43
PE Ratio	37.35	21.89	16.33	13.67	21.71	28.85
PS Ratio	1.13	1.05	1.56	1.82	3.15	4.28
PB Ratio	1.57	1.35	1.35	1.64	2.61	2.81
P/TBV Ratio	1.96	1.69	1.69	2.06	2.90	2.95
P/OCF Ratio	12.00	10.33	29.93	8.20	25.49	25.84
EV/Sales Ratio	1.60	1.50	2.15	1.95	2.85	3.50
EV/EBITDA Ratio	11.67	10.82	12.67	9.30	15.49	20.47
EV/EBIT Ratio	24.70	21.62	21.94	13.24	20.95	29.66
Debt / Equity Ratio	1.00	0.96	0.69	0.74	0.24	0.06
Debt / EBITDA Ratio	5.65	5.37	4.71	3.93	1.59	0.52
Net Debt / Equity Ratio	0.65	0.37	0.38	-0.10	-0.29	-0.48
Net Debt / EBITDA Ratio	3.72	2.10	2.57	-0.52	-1.93	-4.30
Net Debt / FCF Ratio	-16.67	-20.65	-0.95	4.25	2.92	12.13
Asset Turnover	0.58	0.56	0.43	0.55	0.64	0.72
Inventory Turnover	4.31	4.89	4.49	7.52	7.09	6.99
Quick Ratio	0.77	1.08	1.08	3.03	2.38	3.45
Current Ratio	1.39	1.40	1.54	3.34	2.78	3.96
Return on Equity (ROE)	4.34%	6.23%	8.46%	12.94%	12.54%	14.03%
Return on Assets (ROA)	2.10%	2.42%	2.61%	5.07%	5.42%	5.30%
Return on Invested Capital (ROIC)	4.69%	5.84%	7.09%	15.43%	17.78%	16.64%
Return on Capital Employed (ROCE)	4.70%	5.20%	5.20%	7.90%	9.50%	7.40%
Earnings Yield	2.75%	4.57%	6.12%	7.32%	4.61%	3.47%
FCF Yield	-2.50%	-1.34%	-29.26%	-1.40%	-3.86%	-1.42%
Dividend Yield	2.78%	3.38%	3.55%	3.49%	2.18%	1.61%
Payout Ratio	180.65%	126.54%	73.21%	46.60%	35.06%	50.84%
Buyback Yield / Dilution	17.96%	19.74%	-27.25%	-0.23%	-3.09%	-28.98%
Total Shareholder Return	20.74%	23.13%	-23.70%	3.26%	-0.91%	-27.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.